Pharmaceuticals - Community Register

  

Community register of veterinary medicinal products


AUTHORISED  

Product information

Invented name: Leucogen   
Auth. number : EU/2/09/096
INN : Not available
ATC: Anatomical main group: QI - Immunologicals
Therapeutic subgroup: QI06 - Immunologicals for felidae
Pharmacological subgroup: QI06A - Cat
Chemical subgroup: QI06AA - Inactivated viral vaccines
Chemical substance: QI06AA01 - Feline leukaemia virus
(See WHO ATCvet Index)
Indication: Active immunisation of cats from eight weeks of age against feline leukaemia for the prevention of persistent viraemia and clinical signs of the related disease.
Marketing Authorisation Holder: Virbac
1ère Avenue - 2065 m - L.I.D., F-06516 Carros CEDEX, France

  EPAR and active package presentations

Package presentations

Information about presentations can be found in the website of the European Medicines Agency under the section "Product Information".
Likewise, presentations on which there has been a Commission decision are referred in the Summary of Product Characteristics (Annex I to the Commission Decision granting the marketing authorisation) which continues to be available in the Community Register.

 

European Commission proceduresGoto top of the page

Close date procedure Procedure type EMEA number Decision summary publ decision docs annex
19/06/2009 Centralised - Authorisation EMEA/V/C/144 (2009)5019 of 17/06/2009